Doxorubicin Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL (in vials)

Reference Brands: Adriamycin® (EU & US)

Category: Oncology Cancer Care

Doxorubicin is an intravenous chemotherapy drug used to treat cancers such as breast cancer, leukemia, and lymphomas. Available in 10 mg/5 mL, 50 mg/25 mL, and 200 mg/100 mL vials, it is marketed as Adriamycin® in the US and EU, offering key B2B opportunities in oncology. Doxorubicin is available in Injection and strengths such as 10 mg/5 mL, 50 mg/25 mL, 200 mg/100 mL (in vials). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Doxorubicin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Doxorubicin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Doxorubicin is a potent chemotherapy drug used to treat a wide range of cancers, including breast cancer, leukemia, and lymphomas. As an anthracycline, it works by inhibiting DNA replication in cancer cells, leading to cell death. Available in 10 mg/5 mL, 50 mg/25 mL, and 200 mg/100 mL vial strengths, Doxorubicin is marketed as Adriamycin® in both the US and EU. With its significant role in cancer treatment, it offers substantial B2B opportunities for pharmaceutical companies targeting oncology treatments in these regions.